Spero Therapeutics, Inc. SPRO 36.13
Health Care · NASDAQ · Data as of 2026-08-28
Spero Therapeutics, Inc. (SPRO) has delivered +72.8% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1647 of 1983 stocks overall and #205 of 263 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
36.13
Overall Rank
#1647 / 1983
Sector Rank
#205 / 263
Revenue CAGR
+72.8%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio